← FDA DRUG APPROVALS

FDA ANDA · ANDA074436

CYCLOBENZAPRINE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA074436
TYPE
ANDA
ORIGINAL APPROVAL
1994-11-30
LATEST ACTION
2001-04-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CYCLOBENZAPRINE HYDROCHLORIDEDiscontinued
CYCLOBENZAPRINE HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

2001-04-12Manufacturing (CMC) · Supplement 6AP
2000-03-21Manufacturing (CMC) · Supplement 4AP
1997-07-08Manufacturing (CMC) · Supplement 2AP
1997-01-07Manufacturing (CMC) · Supplement 1AP
1994-11-30OriginalOtherAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →